Drawing for EVOLVING HOME SOLUTIONS

USPTO serial 98821847

EVOLVING HOME SOLUTIONS

Reviewed by CopyMark Law Group

Status 973
Filing date
Status date
Registration date
Examiner
BELLOTTI, CHRISTINA L

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EVOLVING HOME SOLUTIONS?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

Owner

  • Madera, Michelle

    Bronx, NY, US

  • Madera, Michelle

    Bronx, NY, US

Goods and services

ClassDescriptionStatusFirst use
036Real estate acquisition services; Real estate agency services; Real estate agent services; Real estate appraisal; Real estate brokerage; Real estate consultancy; Real estate consultation; Real estate escrow services; Real estate financing services; Real estate investment consultancy; Real estate investment services; Real estate lending services; Real estate listing; Real estate management; Real estate management consultation; Real estate management services; Real estate syndication; Real estate time-sharing; Real estate trustee services; Real estate valuationsACTIVE

Prosecution history

DateCodeEventWhat it means
Mar 16, 2026KSNSNOTICE OF SUSPENSION EMAILED - ADMIN REVIEW
Mar 16, 2026KSADSUSPENDED PENDING ADMINISTRATIVE REVIEW
Oct 14, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 7, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 12, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 12, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 6, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 3, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 11, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2025DOCKASSIGNED TO EXAMINER
Oct 25, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2024NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance